GAROFALO HEALTH CARE SPA (GHC.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:GHC - IT0005345233 - Common Stock
5.54 EUR
-0.01 (-0.18%)
We assign a fundamental rating of 4 out of 10 to GHC. GHC was compared to 29 industry peers in the Health Care Providers & Services industry. GHC has an average financial health and profitability rating. While showing a medium growth rate, GHC is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
GHC had positive earnings in the past year.
GHC had a positive operating cash flow in the past year.
Each year in the past 5 years GHC has been profitable.
GHC had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a decent Return On Assets value of 3.66%, GHC is doing good in the industry, outperforming 65.52% of the companies in the same industry.
GHC has a Return On Equity of 9.57%. This is comparable to the rest of the industry: GHC outperforms 55.17% of its industry peers.
GHC has a better Return On Invested Capital (6.52%) than 65.52% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for GHC is in line with the industry average of 6.33%.
The last Return On Invested Capital (6.52%) for GHC is above the 3 year average (4.41%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.66% | ||
| ROE | 9.57% | ||
| ROIC | 6.52% |
ROA(3y)2.83%
ROA(5y)2.81%
ROE(3y)7.12%
ROE(5y)6.88%
ROIC(3y)4.41%
ROIC(5y)3.91%
1.3 Margins
The Profit Margin of GHC (4.62%) is better than 75.86% of its industry peers.
GHC's Profit Margin has declined in the last couple of years.
The Operating Margin of GHC (9.37%) is better than 75.86% of its industry peers.
In the last couple of years the Operating Margin of GHC has declined.
Looking at the Gross Margin, with a value of 44.90%, GHC is in the better half of the industry, outperforming 65.52% of the companies in the same industry.
GHC's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.37% | ||
| PM (TTM) | 4.62% | ||
| GM | 44.9% |
OM growth 3Y-0.19%
OM growth 5Y-3.37%
PM growth 3Y-11.52%
PM growth 5Y-7.03%
GM growth 3Y0.36%
GM growth 5Y-1.06%
2. Health
2.1 Basic Checks
GHC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
GHC has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, GHC has more shares outstanding
GHC has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 1.97 indicates that GHC is not a great score, but indicates only limited risk for bankruptcy at the moment.
GHC has a Altman-Z score (1.97) which is in line with its industry peers.
GHC has a debt to FCF ratio of 70.49. This is a negative value and a sign of low solvency as GHC would need 70.49 years to pay back of all of its debts.
GHC's Debt to FCF ratio of 70.49 is on the low side compared to the rest of the industry. GHC is outperformed by 72.41% of its industry peers.
GHC has a Debt/Equity ratio of 0.67. This is a neutral value indicating GHC is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.67, GHC is doing good in the industry, outperforming 79.31% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.67 | ||
| Debt/FCF | 70.49 | ||
| Altman-Z | 1.97 |
ROIC/WACC1
WACC6.52%
2.3 Liquidity
A Current Ratio of 1.16 indicates that GHC should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.16, GHC is in the better half of the industry, outperforming 65.52% of the companies in the same industry.
A Quick Ratio of 1.12 indicates that GHC should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.12, GHC is doing good in the industry, outperforming 75.86% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.16 | ||
| Quick Ratio | 1.12 |
3. Growth
3.1 Past
GHC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.11%.
Measured over the past years, GHC shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.81% on average per year.
The Revenue has grown by 10.44% in the past year. This is quite good.
Measured over the past years, GHC shows a quite strong growth in Revenue. The Revenue has been growing by 18.92% on average per year.
EPS 1Y (TTM)-12.11%
EPS 3Y5.52%
EPS 5Y8.81%
EPS Q2Q%2.71%
Revenue 1Y (TTM)10.44%
Revenue growth 3Y18.48%
Revenue growth 5Y18.92%
Sales Q2Q%3.08%
3.2 Future
GHC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.47% yearly.
GHC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.51% yearly.
EPS Next Y3.45%
EPS Next 2Y5.05%
EPS Next 3Y6.47%
EPS Next 5YN/A
Revenue Next Year3.78%
Revenue Next 2Y4.6%
Revenue Next 3Y3.74%
Revenue Next 5Y1.51%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 15.39 indicates a correct valuation of GHC.
Compared to the rest of the industry, the Price/Earnings ratio of GHC indicates a somewhat cheap valuation: GHC is cheaper than 72.41% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.60. GHC is valued slightly cheaper when compared to this.
GHC is valuated rather expensively with a Price/Forward Earnings ratio of 17.14.
Compared to the rest of the industry, the Price/Forward Earnings ratio of GHC is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 23.23. GHC is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.39 | ||
| Fwd PE | 17.14 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, GHC is valued a bit cheaper than 79.31% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, GHC is valued a bit more expensive than the industry average as 72.41% of the companies are valued more cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 153.85 | ||
| EV/EBITDA | 7.57 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
GHC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)4.46
PEG (5Y)1.75
EPS Next 2Y5.05%
EPS Next 3Y6.47%
5. Dividend
5.1 Amount
GHC has a Yearly Dividend Yield of 1.54%.
GHC's Dividend Yield is a higher than the industry average which is at 1.45.
Compared to the average S&P500 Dividend Yield of 1.94, GHC is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.54% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y5.05%
EPS Next 3Y6.47%
BIT:GHC (1/2/2026, 7:00:00 PM)
5.54
-0.01 (-0.18%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners11.85%
Inst Owner ChangeN/A
Ins Owners63%
Ins Owner ChangeN/A
Market Cap499.71M
Revenue(TTM)690.85M
Net Income(TTM)31.91M
Analysts84
Price Target6.73 (21.48%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.54% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.39 | ||
| Fwd PE | 17.14 | ||
| P/S | 0.72 | ||
| P/FCF | 153.85 | ||
| P/OCF | 17.89 | ||
| P/B | 1.5 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.57 |
EPS(TTM)0.36
EY6.5%
EPS(NY)0.32
Fwd EY5.83%
FCF(TTM)0.04
FCFY0.65%
OCF(TTM)0.31
OCFY5.59%
SpS7.66
BVpS3.7
TBVpS-0.44
PEG (NY)4.46
PEG (5Y)1.75
Graham Number5.47
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.66% | ||
| ROE | 9.57% | ||
| ROCE | 9.13% | ||
| ROIC | 6.52% | ||
| ROICexc | 6.77% | ||
| ROICexgc | 14.86% | ||
| OM | 9.37% | ||
| PM (TTM) | 4.62% | ||
| GM | 44.9% | ||
| FCFM | 0.47% |
ROA(3y)2.83%
ROA(5y)2.81%
ROE(3y)7.12%
ROE(5y)6.88%
ROIC(3y)4.41%
ROIC(5y)3.91%
ROICexc(3y)4.63%
ROICexc(5y)4.13%
ROICexgc(3y)10.78%
ROICexgc(5y)9.37%
ROCE(3y)6.5%
ROCE(5y)5.8%
ROICexgc growth 3Y7.97%
ROICexgc growth 5Y2.8%
ROICexc growth 3Y6.71%
ROICexc growth 5Y0.74%
OM growth 3Y-0.19%
OM growth 5Y-3.37%
PM growth 3Y-11.52%
PM growth 5Y-7.03%
GM growth 3Y0.36%
GM growth 5Y-1.06%
F-Score5
Asset Turnover0.79
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.67 | ||
| Debt/FCF | 70.49 | ||
| Debt/EBITDA | 2.47 | ||
| Cap/Depr | 94.13% | ||
| Cap/Sales | 3.57% | ||
| Interest Coverage | 6.62 | ||
| Cash Conversion | 30.7% | ||
| Profit Quality | 10.18% | ||
| Current Ratio | 1.16 | ||
| Quick Ratio | 1.12 | ||
| Altman-Z | 1.97 |
F-Score5
WACC6.52%
ROIC/WACC1
Cap/Depr(3y)82.25%
Cap/Depr(5y)102.09%
Cap/Sales(3y)4.73%
Cap/Sales(5y)5.79%
Profit Quality(3y)118.21%
Profit Quality(5y)101.66%
High Growth Momentum
Growth
EPS 1Y (TTM)-12.11%
EPS 3Y5.52%
EPS 5Y8.81%
EPS Q2Q%2.71%
EPS Next Y3.45%
EPS Next 2Y5.05%
EPS Next 3Y6.47%
EPS Next 5YN/A
Revenue 1Y (TTM)10.44%
Revenue growth 3Y18.48%
Revenue growth 5Y18.92%
Sales Q2Q%3.08%
Revenue Next Year3.78%
Revenue Next 2Y4.6%
Revenue Next 3Y3.74%
Revenue Next 5Y1.51%
EBIT growth 1Y-8.88%
EBIT growth 3Y18.26%
EBIT growth 5Y14.91%
EBIT Next Year68.09%
EBIT Next 3Y22.98%
EBIT Next 5Y16.09%
FCF growth 1Y-88.34%
FCF growth 3Y4.79%
FCF growth 5Y6.69%
OCF growth 1Y-35.2%
OCF growth 3Y-1.23%
OCF growth 5Y13.09%
GAROFALO HEALTH CARE SPA / GHC.MI FAQ
What is the ChartMill fundamental rating of GAROFALO HEALTH CARE SPA (GHC.MI) stock?
ChartMill assigns a fundamental rating of 4 / 10 to GHC.MI.
What is the valuation status for GHC stock?
ChartMill assigns a valuation rating of 3 / 10 to GAROFALO HEALTH CARE SPA (GHC.MI). This can be considered as Overvalued.
How profitable is GAROFALO HEALTH CARE SPA (GHC.MI) stock?
GAROFALO HEALTH CARE SPA (GHC.MI) has a profitability rating of 6 / 10.
What is the financial health of GAROFALO HEALTH CARE SPA (GHC.MI) stock?
The financial health rating of GAROFALO HEALTH CARE SPA (GHC.MI) is 4 / 10.
What is the expected EPS growth for GAROFALO HEALTH CARE SPA (GHC.MI) stock?
The Earnings per Share (EPS) of GAROFALO HEALTH CARE SPA (GHC.MI) is expected to grow by 3.45% in the next year.